Real-World Health Care Services Utilization Associated with the Management of Patients with Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study

Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization of health care services among the relapsed/refractory MM (RRMM) population are scarce.

Source: Clinical Lymphoma, Myeloma and Leukemia - July 14, 2023 Category: Hematology Authors: Enrique M. Ocio, Carmen Montes-Gais án, Gabriela Bustamante, Sebastián Garzón, Esther González, Ernesto Pérez-Persona, Verónica González-Calle, Maialen Sirvent, José M. Arguiñano, Yolanda González, Rafael Ríos, Dunia de Miguel, Marta Grande, Al Tags: Original Study Source Type: research